Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000194347 | SCV000202515 | likely benign | not specified | 2016-07-21 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000194347 | SCV000247053 | likely benign | not specified | 2015-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000234647 | SCV000289926 | benign | Cortical dysplasia-focal epilepsy syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000297884 | SCV000467237 | uncertain significance | Pitt-Hopkins-like syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000234647 | SCV000467238 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711326 | SCV000841667 | benign | not provided | 2017-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312673 | SCV000847251 | likely benign | Inborn genetic diseases | 2016-08-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000711326 | SCV001946049 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000711326 | SCV002545574 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | CNTNAP2: BP4, BP7, BS2 |
Genome Diagnostics Laboratory, |
RCV000194347 | SCV001929444 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000711326 | SCV001971075 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003917492 | SCV004735671 | benign | CNTNAP2-related disorder | 2023-01-05 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |